EVLO vs. HSTO, NAVB, CALA, SCPS, VAXX, CMRA, GNCAQ, GNCA, SMFL, and ARDS
Should you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Histogen (HSTO), Navidea Biopharmaceuticals (NAVB), Calithera Biosciences (CALA), Scopus BioPharma (SCPS), Vaxxinity (VAXX), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Smart for Life (SMFL), and Aridis Pharmaceuticals (ARDS). These companies are all part of the "pharmaceutical products" industry.
Evelo Biosciences vs. Its Competitors
Histogen (NASDAQ:HSTO) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, community ranking, valuation, earnings and profitability.
Evelo Biosciences received 163 more outperform votes than Histogen when rated by MarketBeat users. Likewise, 60.50% of users gave Evelo Biosciences an outperform vote while only 58.33% of users gave Histogen an outperform vote.
In the previous week, Evelo Biosciences had 1 more articles in the media than Histogen. MarketBeat recorded 1 mentions for Evelo Biosciences and 0 mentions for Histogen. Histogen's average media sentiment score of 0.00 equaled Evelo Biosciences'average media sentiment score.
Histogen has higher revenue and earnings than Evelo Biosciences.
Histogen has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500.
0.3% of Evelo Biosciences shares are held by institutional investors. 3.3% of Histogen shares are held by company insiders. Comparatively, 1.0% of Evelo Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Histogen and Evelo Biosciences tied by winning 4 of the 8 factors compared between the two stocks.
Get Evelo Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evelo Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:EVLO) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy EVLO Stock Free EVLO Stock Alerts